Diassess is a medical diagnostic s tart-up that has developed a test kit that allows any cell phone to perform rapid DNA-based disease detection, in a clinic or at-home, within 30 minutes. This technology bypasses centralized medical lab testing and streamlines patient care. The company is focusing on developing tests for STDs, influenza, and agriculture. Over the past 4 years, the Gates Foundation, DARPA, and NIH have awarded the co-founders $3.25M in grant funding to develop the technology. Diassess has validated the technology through a blinded preclinical trial achieving 100% accuracy and obtained strong interest from hospitals, clinics , and large pharm a. Recently, Diassess has closed a VC-funded seed round here in silicon valley, have been awarded our 2nd NIH grant, and we are now developing relations hips with the world’s largest pharmaceutical and chemical companies.